MacroGenics reported 48K in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4021M 259M
Amgen AMGN:US $ 1561M 157M
AstraZeneca AZN:LN 2279M 790M
Biogen BIIB:US $ 753.9M 93.8M
Bristol Myers Squibb BMY:US $ 2471M 115M
Daiichi Sankyo 4568:JP Y 88830M 3109M
Eli Lilly And LLY:US $ 2072.1M 21.9M
Epizyme EPZM:US $ 2.64M 516K
Gilead Sciences GILD:US $ 1424M 1203M
Johnson & Johnson JNJ:US $ 7598M 357M
Karyopharm Therapeutics KPTI:US $ 1.43M 684K
MacroGenics MGNX:US 48K 899K
Merk MRK:US $ 5334M 1507M
Pfizer PFE:US $ 10010M 399M
Puma Biotechnology PBYI:US $ 10.84M 1.05M
Regeneron Pharmaceuticals REGN:US $ 404.9M 577.7M
Seattle Genetics SGEN:US $ 87.63M 0.94M